Portal de investigación
ESTUDIO ABIERTO DE SEGURIDAD Y SOBRE LA EFICACIA DE REFACTO AF EN PACIENTES NO TRATADOS PREVIAMNTE, EN CONDICIONES ASISTENCALES HABITUALES.
Datos básicos
- Protocolo:
- 3082B2-4434-WW
- EUDRACT:
- 2008-008436-93
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Año de incio:
- 2010
- Año de finalización:
- 2012
Objetivos del proyecto
Observaciones: Estado Comité: CENTRO CERRADO
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
Resultados del Ensayo Clínico
Association of haplotypes (H) 1 and 3 of the endothelial protein c receptor gene (PROCR) with venous thromboembolism
Bonet, Elena; (...); Espana, Francisco
Article. 10.1016/j.thromres.2012.08.027. 2012
Deletion of F8 gene involving the segmental repeat int22h and one of the two extragenic copies in a carrier woman
Casana, P.; (...); Aznar, J. A.
Article. 2011
Efficacy of factor IX Grifols(®) in surgery: experience of an international multicentre retrospective study.
Pérez-Garrido R; (...); Rescia V
Letter. 10.1111/j.1365-2516.2012.02919.x. 2012
Emerging viral infections--a potential threat for blood supply in the 21st century.
de Mendoza C; (...); Soriano V
Article. 2012
First application of MLPA method in severe von Willebrand disease. Confirmation of a new large VWF gene deletion and identification of heterozygous carriers.
Cabrera N; (...); Aznar JA
Letter. 10.1111/j.1365-2141.2010.08400.x. 2011
Haplotypes of the endothelial protein C receptor gene and circulating protein C levels
Martos, Laura; (...); Espana, Francisco
Article. 10.1016/j.thromres.2012.08.026. 2012
Identification of mutations in the protein C gene in a panel of 65 Spanish families with protein C deficiency
Martos, Laura; (...); Espana, Francisco
Article. 10.1016/j.thromres.2012.08.029. 2012
Individualization of prophylaxis with recombinant factor VIII in severe or moderate hemophilia A
Vericat, JEM; (...); Bonanad, S
Meeting Abstract. 2018
Individualized Prophylactic Treatment with Recombinant Factor VIII in Severe or Moderate Haemophilia a Patients. Association Between Pharmacokinetic Parameters and Clinical Variables
Megias-Vericat, Juan Eduardo; (...); Bonanad, Santiago
Meeting Abstract. 10.1182/blood.V128.22.3802.3802. 2016
Is on-demand treatment effective in patients with severe haemophilia?
Aznar JA; (...); Moret A
Article. 10.1111/j.1365-2516.2012.02806.x. 2012
Kinetics of the interaction between anti-FVIII antibodies and FVIII from therapeutic concentrates, with and without von Willebrand factor, assessed by surface plasmon resonance.
Grancha S; (...); Aznar JA
Article. 10.1111/j.1365-2516.2012.02858.x. 2012
Large deletion in the Factor VIII gene (F8) involving segmental duplications in int22h shows no haematological phenotype in female carriers, but may be embryonic lethal in males.
Casaña P; (...); MARTINEZ, F.
Letter. 10.1111/j.1365-2141.2012.09092.x. 2012
Liver transplantation in Spanish haemophiliacs.
Aznar JA; (...); Soto I
Letter. 10.1111/j.1365-2516.2011.02658.x. 2012
The Spanish Immune Tolerance Induction Registry: 2009 update
Haya, S.; (...); Aznar, J. A.
Article. 2010